Therapy Areas: Vaccines
hVIVO completes pilot study for hMPV challenge model
13 January 2025 - hVIVO plc (AIM: HVO), a contract research organisation specialising in infectious and respiratory disease trials, announced on Monday that it has completed a successful pilot charact...
Merck's Gardasil approved for males in China
8 January 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Wednesday that China's National Medical Products Administration has ...
Brii Bio acquires BRII-179 IP rights
2 January 2025 - China-based biotechnology company Brii Biosciences Limited (HK2137) announced on Tuesday that it has entered into an agreement with biopharmaceutical company VBI Vaccines, Inc. and ce...
Valneva and Serum Institute of India partner to expand chikungunya vaccine access in Asia
19 December 2024 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) on Thursday announced a partnership with vaccines manufacturer Serum Institute of India (SII) to expand access to Valne...
Orexo partners with Abera to develop nasal powder vaccines
17 December 2024 - Swedish pharmaceutical company Orexo AB (STO:ORX) (OTCQX:ORXOY) on Tuesday announced a collaboration with Abera Bioscience to develop nasal powder vaccines using Orexo's Amorph...
SK bioscience begins clinical trials for mRNA Japanese encephalitis vaccine
13 December 2024 - Biotech company SK bioscience announced on Thursday that it has received approval from Australia's Human Research Ethics Committee for Phase 1/2 clinical trials of its mRNA-bas...